Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021

Detalles Bibliográficos
Autores principales: Dooling, Kathleen, Gargano, Julia W., Moulia, Danielle, Wallace, Megan, Rosenblum, Hannah G., Blain, Amy E., Hadler, Stephen C., Plumb, Ian D., Moline, Heidi, Gerstein, Jack, Collins, Jennifer P., Godfrey, Monica, Campos-Outcalt, Doug, Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., Oliver, Sara E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459897/
https://www.ncbi.nlm.nih.gov/pubmed/34555007
http://dx.doi.org/10.15585/mmwr.mm7038e2

Ejemplares similares

Ejemplares similares